Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life

Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James C. Bennett, Megan Croal, Charles DeBattista, Boadie Waid Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John Richard Kelly, Molly Lennard-Jones, Rasmus Wentzer Licht, Lindsey Marwood, Sunil J. Mistry, Tomáš Páleníček, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie Simmons, Jair C. Soares, Metten Somers, S. C. Stansfield, and 11 more

View at source ↗Article175 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1016/j.jad.2023.01.108
Published
Feb 3, 2023
Venue
Journal of Affective Disorders
DOI
10.1016/j.jad.2023.01.108
PubMed
36740140
Categories
Psychedelics and Drug Studies
License
cc-by-nc-nd
Provenance
openalex

Topics